Technology Transfer Executive

Technology Transfer Executive is responsible for supporting formulation technology transfer activities, plant-scale execution, batch coordination, process documentation, and cross-functional communication between formulation, production, QA, QC, and regulatory teams. The requires B.Pharmacy or M.Pharmacy qualification with 2 to 5 years of plant experience in formulation. Candidates should have strong knowledge of OSD formulation, scale-up batches, process transfer, documentation, GMP, and manufacturing troubleshooting.

Role & Responsibilities

• Support technology transfer activities from formulation development to commercial plant execution.
• Coordinate scale-up, exhibit, validation, and commercial batch manufacturing activities.
• Review formulation process details, batch records, process parameters, and technical documents.
• Work closely with production, QA, QC, regulatory, and formulation development teams.
• Monitor plant batches during manufacturing and identify process-related challenges.
• Support troubleshooting during granulation, compression, coating, and other OSD processes.
• Ensure transferred processes are practical, reproducible, and compliant with GMP standards.
• Prepare and maintain technology transfer documents, reports, protocols, and checklists.
• Support process validation and product lifecycle documentation.
• Track critical process parameters and critical quality attributes during batch execution.
• Coordinate with plant teams for equipment suitability, batch readiness, and material availability.
• Assist in gap analysis between development process and plant manufacturing process.
• Support regulatory and audit documentation related to transferred products.
• Maintain confidentiality of product, formulation, process, and technical information.
• Ensure smooth, compliant, and timely technology transfer for formulation products.

VKT Pharma Pvt. Ltd. is a quality-driven pharmaceutical company specializing in the research, development, manufacturing, and marketing of finished dosage formulations. Established in 2006 and headquartered in Hyderabad, Telangana, the company provides end-to-end pharmaceutical solutions through a vertically integrated business model that spans product development, manufacturing, regulatory support, and global distribution.

VKT Pharma focuses on developing solid oral dosage forms, including tablets, capsules, and ready-to-fill immediate and modified-release pellets. The company also offers Novel Drug Delivery Systems (NDDS) and Contract Research and Manufacturing Services (CRAMS), serving customers in more than 10 countries through strategic partnerships and alliances.

Vision

To become one of the leading global generic pharmaceutical companies by providing quality medicines at affordable prices, enhancing the quality of human life through innovation, sustainability, and a commitment to improving healthcare standards.

Mission

• To provide high-quality medicines at affordable prices through vertical integration across the pharmaceutical value chain.
• To showcase India's manufacturing capabilities to global pharmaceutical companies.
• To offer state-of-the-art facilities for manufacturing finished dosage formulations.
• To develop and market proprietary pharmaceutical brands.
• To build a sustainable pharmaceutical business focused on quality and innovation.

Core Business Areas

VKT Pharma's expertise includes:

• Finished Dosage Formulations
• Tablets
• Capsules
• Immediate and Modified Release Pellets
• Novel Drug Delivery Systems (NDDS)
• Contract Research & Manufacturing Services (CRAMS)
• Product Development
• Pharmaceutical Consulting
• Technology Transfer and Licensing

Therapeutic Segments

The company develops products across a variety of therapeutic areas, including:

• Anti-ulcer
• Anti-fungal
• Anti-epileptic
• Anti-retroviral
• Gastroenterology
• Pain Management
• Antibiotics
• Anti-inflammatory therapies

Manufacturing and Research Infrastructure

VKT Pharma operates modern facilities that include:

• WHO-GMP compliant manufacturing infrastructure
• Dedicated Quality Assurance (QA) and Quality Control (QC) systems
• In-house Research & Development Centre
• Analytical and Formulation Development Laboratories
• Pilot Plant for product development
• Facilities for large-scale production of tablets, capsules, and pellets

Quality Policy

Quality is central to VKT Pharma's operations. The company follows stringent Current Good Manufacturing Practices (cGMP) and maintains comprehensive Quality Management Systems to ensure that every product meets national and international regulatory standards for safety, efficacy, and consistency.

Global Presence

Through alliances, joint ventures, and strategic partnerships, VKT Pharma supplies pharmaceutical products and services to customers in 10+ countries, strengthening its presence in international generic pharmaceutical markets.

Leadership

The company is led by Mr. P. Ramesh Babu, Chairman & Managing Director, whose vision focuses on innovation, quality, and expanding VKT Pharma's global presence in affordable generic medicines.

Why Choose VKT Pharma?

• Nearly two decades of pharmaceutical manufacturing experience.
• Vertically integrated business model.
• Advanced R&D and manufacturing capabilities.
• Expertise in complex oral solid dosage formulations.
• Strong commitment to quality and regulatory compliance.
• Global partnerships across multiple international markets.
• Comprehensive pharmaceutical development and manufacturing solutions.

Corporate Office

• Address: Plot No. 72, H. No. 8-2-334/3 & 4, 4th Floor, Road No. 5, Opposite SBI Executive Enclave, Banjara Hills, Hyderabad – 500034, Telangana, India.
• Manufacturing Plant: Sy. No. 21–27, Derasam Village, Ranasthalam Mandal, Srikakulam District – 532409, Andhra Pradesh, India.

Our Commitment

VKT Pharma is committed to improving global healthcare by developing safe, effective, and affordable pharmaceutical products. Through innovation, scientific excellence, advanced manufacturing, and a strong quality culture, the company continues to expand its as a trusted partner in the global pharmaceutical industry.